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Abstract: Many people with severe Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS)
commonly receive no care from healthcare professionals, while some have become distanced from
all statutory medical services. Paradoxically, it is often the most seriously ill and needy who are the
most neglected by those responsible for their healthcare. Reasons for this include tensions around
the complexity of making an accurate diagnosis in the absence of a biomarker, the bitter debate
about the effectiveness of the few available treatments, and the very real stigma associated with the
diagnosis. Illness severity often precludes attendance at healthcare facilities, and if an individual is
well enough to be able to attend an appointment, the presentation will not be typical; by definition,
patients who are severely affected are home-bound and often confined to bed. We argue that a holistic
model, such as “Compassion in Practice”, can help with planning appointments and caring for
people severely affected by ME/CFS. We show how this can be used to frame meaningful interactions
between the healthcare practitioners (HCPs) and the homebound patient.
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1. Introduction
1.1. ME/CFS and the Needs of the Severely Affected Individual
ME/CFS is a complex and multifactorial disease; the World Health Organisation has described
ME/CFS as a neurological disorder in the International Classification of Functioning, Disability and
Health since 1969 [1]. It is also highly stigmatised [2], and there is currently neither a validated
biomarker nor an effective treatment. Disease manifestation can vary between affected individuals,
and some routine clinical examinations and blood tests may not evidence abnormalities [3]. However,
a careful clinical examination, which should be part of a clinical assessment, may show subtle
abnormalities [4]. People with severe ME/CFS, estimated as 25% of those affected [5], have been defined
as being almost exclusively housebound and unable to attend healthcare consultations, and often
bedbound all or some of the time [4]. Multiple studies worldwide [6] have uncovered abnormalities in
the central and autonomic nervous system, as well as changes to the metabolic and immunological
systems. Severe or striking fatigue, which is often disabling, must have been present for at least
six consecutive months (in adults) in order to meet currently accepted diagnostic guidelines [7–9].
While ME/CFS can affect multiple systems, many people with mild/moderate ME/CFS continue to
function “deceptively normally” by carefully planning their activities and periods of rest. This may
involve, for example, managing to hold down a job but not taking part in any social activities in the
evenings and at weekends so that they can rest, significantly impacting friendships and quality of life.
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However, other patients are severely functionally impaired, and physical or mental exertion beyond
a personal threshold can exacerbate symptoms; this is commonly known as post-exertional malaise
(PEM). PEM can be debilitating and increases the individual’s dependency on others for hours, days,
weeks or even months. The vocabulary to describe the experience of people with severe ME/CFS is
inadequate, and words such as malaise or fatigue diminish and deny the grim reality of the disease.
ME/CFS has a prevalence of between 0.2 and 0.4%; recent estimates of those affected in the UK
give a figure of between 150,000 and 250,000 people [10]. Two to four times as many women as
men are affected, which is similar to multiple sclerosis (MS) and some other autoimmune diseases,
where major fatigue is also a symptom. A GP practice of 10,000 patients could have up to 40 people
with ME/CFS (PWME), with 25% severely affected [5]. PWME have been found to be more functionally
impaired than people with cancer or other chronic diseases [11]. ME/CFS is potentially life-shortening,
although registered deaths from ME/CFS are rare; between 2001 and 2016, 88 deaths in England and
Wales were partly or fully attributable to ME/CFS [12]. This is a disease of low prestige, and PWME
often experience damaging negative encounters with GPs, nurses, and other healthcare practitioners
(HCPs) [13]; disrespectful treatment and trivialising of legitimate symptoms may lead to loss of agency
and alienation from all medical services. PWME are often made to feel, in the words of one parent carer,
“that they are second-class citizens, malingerers or at least somehow responsible for their own misfortune” [14].
In the face of such discrimination, we strongly believe that HCPs are duty-bound to ensure that the
person with severe ME/CFS receives the person-centred care she/he needs, despite the fact that, as is
understood currently, little can be done to change the pattern of the illness.
As part of the CureME research team at the London School of Hygiene and Tropical Medicine,
we have visited a cohort of nearly 100 patients housebound by ME/CFS on multiple occasions, in order
to enrol them in the UK ME/CFS Biobank (UKMEB) [15]. After considering our experiences and
insights from these unique encounters in a methodical way, we argue that a holistic model, such as
“Compassion in Practice” [16], can help with planning and caring for people severely affected by
ME/CFS. We show how this can be used to frame meaningful interactions between the HCPs and the
homebound patient.
To substantiate this discussion, we present in Table 1 an analysis of the frequency and severity of
symptoms reported by data available from an early subsample of our cohort with severe presentation
of ME/CFS (n = 57), whose gender breakdown reflects the accepted 3:1, F:M ratio [10]. These are
accompanied by revealing quotes from those visited by the CureME team:
Table 1. Common symptoms affecting people with severe Myalgic Encephalopathy/Chronic Fatigue
Syndrome (ME/CFS) seen by CureME.
Symptom
PWSME * with Symptom Symptom Reported
as Severe (%)(n = 57; 44 F, 13M)
a Unrefreshing sleep 100 70
“When I waken, often in the very late morning, I feel no more rested than I did at the end of the day before; everything
is an effort no matter how long the time spent asleep.” (F aged 20–29)
b
Disabling fatigue 100 n/a
Sleep problems 83 65
“I can only describe a good day as trying to walk through water; on a bad day, the water becomes treacle.”
(M aged 40–49)
c Exercise intolerance (PEM) 100 90
“If my daughter cleans her teeth herself, that is it for a week. She can’t do anything more.” (Parent describing F
aged 40–49)
d
Pain after exertion/activity 84 70
Muscle pain 96 50
“I would love to know what one, single day without pain was like; I have quite forgotten. This pain is relentless.”
(F aged 18–30)
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Table 1. Cont.
Symptom PWSME * with Symptom Symptom Reported
as Severe (%)(n = 57; 44 F, 13M)
e Intolerance to standing 81 50
“Standing is a nightmare–my heart pounds, my legs shake within minutes, I become dizzy and feel that I will faint.”
(M aged 50–59)
f Concentration problems 96 43
“Reading is like trying to listen to the radio when there is so much interference that you can only hear the odd word . . . ”
(F aged 40–49)
g
Difficulty in finding words 96 32
Difficulty in making decisions 75 35
“When someone visits, I have to choose. I can either eat a biscuit and have a cup of tea or listen and respond. I cannot
do both.” (F aged 30–39)
h
Brain fog/cognitive dysfunction 95 45
Slow thinking 88 32
“Sometimes I grasp at words, feeling like a toddler learning to speak all over again. I was studying for my PhD when I
got ill.” (F aged 30–39)
i Short-term memory problems 95 33
“I am so sorry. I know you just asked me to do something, but I can’t remember what.” (F aged 40–49)
j
Difficulty in understanding 86 31
Difficulty in retaining information 89 35
“I have to write that down straight away or I forget what you said. And I forget I need to write it down!” (M aged 30–39)
k Unusual sensitivity to light and/or noise 91 45
“Would you mind just shining a light on my arm to take blood? Away from my eyes? I just can’t tolerate any light.”
(M aged 20–29)
“The whole family suffers because I can’t bear music playing or the chatter of voices–and yet I long to enjoy those things
again.” (F aged 20–29)
l New sensitivities to food, medication, chemicals or odours 88 43
“Please don’t wear freshly washed clothes as the smell of detergent or softener can worsen her symptoms.” (Parent of F
aged 50–59)
m Intolerance to heat and cold 81 57
“I sometimes think this must be what the menopause is like for women. I vacillate between hot sweats and feeling icy
cold within minutes–for no apparent reason” (M aged 40–49)
n Allergies/hypersensitivities 80 63
“I have had to rearrange the appointment as she is still unable to leave the house due to the severe reaction to clothes
and anything that touches her skin-you can understand that is a big, big problem.” (Parent of F aged 18–30)
o
Gastrointestinal symptoms 79 40
Sickness and nausea 79 16
“I became unable to tolerate different types of food-even the smell of food being cooked. Even water made me feel sick”
(F aged 30–39)
* PWSME—people with severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. The letter to the left of a
particular symptom is used to reference the symptom in the text following the table.
1.2. Responsibility and Compassion
Responsibility and compassion should guide all interactions between HCPs and patients and are
critical to the therapeutic relationship; they are particularly important when HCPs interact with people
with severe ME/CFS. The following approaches exemplify the ways that attributes, including empathy,
respect and dignity, can be evident in many practical tasks when medical encounters are carefully
planned and executed.
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1.2.1. Arranging a Visit
Most appointments, either face-to-face or virtual, are ideally scheduled for after midday as many
people with severe ME/CFS need to rest until then due to erratic sleep patterns (a). Connecting with
those most severely affected may require some persistence, and the practitioner should always ensure
that his/her tone of voice (k) is appropriate for someone seriously ill, and that questions are simple,
requiring short answers. People with ME/CFS often make an enormous effort to prepare for the HCP
visit, and the post visit malaise and exhaustion (c, d) is never witnessed by the visiting HCP but only
by those who remain with the patient. The PEM caused by such efforts may continue for hours, days or
even weeks.
Looking after people with severe ME/CFS at home may require ongoing commitment from the
HCP over many years, as improvement in the condition is uncommon; the HCP may need to schedule
short visits at regular intervals, aiming to address one or two problems at each visit commensurate
with the health of the individual.
1.2.2. Preparing for a Visit
When planning the visit to the person with severe ME/CFS, the HCP should avoid smoking or the
use of perfumes or fragranced lotions, as sensitivities to chemicals or odours (l) are common (4, 5);
patients may even request that clothes are not freshly laundered because of the effect of fragranced
detergents. HCPs with symptoms of viral infections should avoid visits, as there is evidence that the
altered immunological status in ME/CFS makes people more susceptible to infection [17]. On entering
the home of any person with severe ME/CFS, the HCP should offer to remove shoes and be seen to
undertake thorough hand hygiene.
Visiting someone with severe ME/CFS necessitates use of the HCP’s experience and expertise to
priorities the patient’s agenda according to need, to make the visit profitable for both parties. In the
current absence of effective treatments for ME/CFS, the person with severe ME/CFS is often very aware
of which strategies help or hinder their ability to function. ME/CFS charities (see Table 2) are a rich
resource, and the well-informed HCP should know how to access websites, printing information in
advance to hand out if appropriate and helpful.




Action for M.E. https://www.actionforme.org.uk/
The ME Trust https://www.metrust.org.uk/
25% M.E. Group-Supporting Those with Severe M.E. https://25megroup.org
1.2.3. The Home Visit
The visiting practitioner should assess the disease severity and what that means for the patient
using observational skills, without judgment or agenda, to better understand the health and social
needs of the individual. The observant HCP will seek clues about who the individual was before the
onset of disease; patients have often had to redefine their sense of self out of necessity [18]. A common
consequence of the disease is physical, emotional and intellectual isolation; family and friends are
often estranged, partnerships and marriages flounder, and studies are curtailed and jobs are lost,
with ensuing loss of income [19].
HCPs without appropriate expertise may be reluctant to engage with PWME leading to inequity
in treatment. PWME are often better informed about the disease than the visiting practitioner. Lack of
support from established medical services force many to draw on e-resources, including support
groups and online forums. In the absence of validation and support from the medical community,
Healthcare 2020, 8, 197 5 of 7
some PWME self-manage the illness, gathering information to legitimise the illness [20] and in an
attempt to find sources of help. Taking a proactive stance with their own health differentiates PWME
from people with clinical depression, and HCPs need to understand that it is the disease that inhibits
activity (b, c) rather than lack of motivation. This can challenge the practitioner used to steering
the therapeutic relationship who may need to acknowledge their limitations. People with severe
ME/CFS are as susceptible to other diseases as the general population, and may be at higher risk of
some diseases [21]. It is therefore important that PWSME are thoroughly medically reviewed on a
regular basis, as well as when there is deterioration in their health status, or when presenting signs or
symptoms that could be due to new comorbidities, which could be treated.
“Brain fog” (h) or cognitive dysfunction is common in PWME; time and patience are required
to help the patient to make sense of his/her illness. It is often difficult and time-consuming to take a
coherent medical history, not only because information processing and concentration skills (f, g, h, i,
j) may be diminished by the disease but also because this is a disease with no clear natural history,
in which symptoms can vary both from person to person and from day to day, over the course of
the disease. Listening and hearing imply trust, which is essential to any therapeutic relationship.
The individual with severe ME/CFS may be familiar with disbelief and skepticism, and therapeutic
progress often involves belief in the patient’s symptoms and feelings.
Some people with severe ME/CFS may lie in a darkened room with earplugs in and may exhibit
increased sensitivity to light, sound and touch (k, m, n); struggle to share information (f, h); or be
so wary of PEM that they are fearful of articulating the things that they want or need to share (c).
Others may seem animated and engaged, making it difficult for the practitioner to recognize the extent
of their illness. Practitioners should use tone of voice (k) and pressure of touch appropriate to the
individual’s sensitivities.
Apart from frailty, physical examination generally reveals little, and blood work, important
to exclude other diagnoses, is often normal. Some severely affected individuals may appear
undernourished; this often follows food intolerance and allergies (o) and is rarely a manifestation of
anorexia nervosa [22]. People with severe ME/CFS may only be able to stand (e) for a few moments,
if at all, and signs of weakness may be obvious. Handgrip measures are markedly reduced in the
severely affected and rapidly decline when repeated [23].
The HCP should encourage balance between activity and rest, including during the encounter,
to minimize any subsequent PEM and pain (c, d). There are times when the patient may risk PEM to
accomplish something, and the HCP can guide the planning of such activities to minimize the risk of
PEM. Such activities may, for the most severely affected, simply include producing a urine sample or
raising an arm to have a BP cuff put on.
People with severe ME/CFS are disabled by their symptoms (b), and this may be an opportunity
for the HCP to offer information about and access to disability aids and allowances. In the UK, benefits
include Attendance Allowance and Personal Independence Payments. The ME/CFS charities are a rich
resource for further information (Table 2).
Living with severe ME/CFS requires enormous courage. The inevitable reduction or loss of a
societal role means that people with ME/CFS are unable fully to engage with family and friends.
Not only do people with severe ME/CFS have to come to terms with a long-term, disabling illness,
but they may also have to cope with doubts about its authenticity. Reactive depression and anxiety are
common for people with severe ME/CFS as in any long-term, disabling illness, and suicide is a possible
outcome in this patient group [24], so the HCP should always be sensitive to signs of deteriorating
mental health and treat it appropriately.
The therapies and alternative treatments that people with severe ME/CFS sometimes embrace can
seem unscientific to the HCP, but are sometimes turned to out of desperation; unless they could be
detrimental to the individual’s health or involve unreasonable expense, the HCP should endeavor
to support the patient in his/her chosen path. When patients face financial difficulties, the HCP
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must continue to support the severely affected individual to help them to manage that possible
additional burden.
2. Conclusions
We believe that compassion is central to the care of people with ME/CFS. Despite the current
absence of curative treatments for people with severe ME/CFS, the HCP has a responsibility to provide
care through a relationship based on empathy, respect and dignity. By supporting the individual
with compassion and competence and acknowledging and learning from the patient’s experience,
the encounter with the housebound patient can be both effective and worthwhile. The first step in the
therapeutic relationship is to believe and trust the individual: to articulate that you, the practitioner,
hear what your patient is saying and recognise that their experience is legitimate.
This severe, complex multisystem disease has long been misjudged by the healthcare profession.
Educating practitioners about the needs of those most severely affected by ME/CFS will help drive the
step change in understanding and belief, compassion and empathy required to care for all patients
with ME/CFS.
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